4 mg & 8 mg - Intranasal Emergency Opioid Antagonist Product 4 mg - $23.50 / 2-dose kit 8 mg…

The Florida Department of Children and Families (DCF) has awarded contract C68182 for the procurement of emergency opioid antagonist products, valued at $2,000,000.00. The contract covers the period from December 1, 2025, through June 30, 2026, with a total quantity of 2,000,000 units. The line items specify two dosage variants: a 4 mg two-dose kit priced at $23.50 and an 8 mg two-dose kit priced at $42.00, to be acquired on an as-needed basis under Request for Proposal (RFP) 2526 018.

The contract enables DCF to maintain a blanket purchase order for emergency opioid antagonist products, critical for addressing potential overdose situations. The procurement supports the state's public health intervention strategies by ensuring access to naloxone, a medication designed to rapidly reverse opioid overdose effects. The significant volume of units and the contract's relatively short performance period suggest a strategic approach to managing opioid-related emergencies within Florida's public health and social services infrastructure.